Previous Close | 1.8300 |
Open | 1.8000 |
Bid | 1.9600 x 800 |
Ask | 2.0000 x 800 |
Day's Range | 1.8000 - 1.9800 |
52 Week Range | 0.8660 - 8.0500 |
Volume | |
Avg. Volume | 6,012,538 |
Market Cap | 25.149M |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.8670 |
Earnings Date | Aug 15, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 6.80 |
Subscribe to Yahoo Finance Plus to view Fair Value for AUVI
Some of the losses seen by insiders who purchased US$92k worth of Applied UV, Inc. ( NASDAQ:AUVI ) shares over the past...
MOUNT VERNON, NY, August 11, 2022--Applied UV, Inc. (NasdaqCM: AUVI) ("Applied UV" or the "Company"), a pathogen elimination technology company that applies the power of narrow-range ultraviolet light ("UVC") for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, announced that the Company will be hosting an investor conference call and live webcast on Tuesday, August 16, 2022 at 9:00 am ET to review its financial
MOUNT VERNON, N.Y., July 22, 2022--Applied UV, Inc. (NasdaqCM: AUVI) ("Applied UV" or the "Company"), a pathogen elimination technology company that applies the power of narrow-range ultraviolet light ("UVC") for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, today announced its Board of Directors has authorized the cash dividend to holders of Applied UV’s 10.5% Series A Cumulative Perpetual Preferred Stock.